Web Analysis for Okta - okta.business
It is a domain having business extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were reported recently by users, okta.business is SAFE to browse.
PageSpeed Score
Siteadvisor Rating
Traffic Report
Daily Unique Visitors: | Not Applicable |
Daily Pageviews: | Not Applicable |
Estimated Valuation
Income Per Day: | $ 0.15 |
Estimated Worth: | $ 8.95 |
Search Engine Indexes
Google Indexed Pages: | Not Applicable |
Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
Google Backlinks: | 443,000 |
Bing Backlinks: | Not Applicable |
Safety Information
Google Safe Browsing: | No Risk Issues |
Siteadvisor Rating: | Not Applicable |
WOT Trustworthiness: | Not Applicable |
WOT Child Safety: | Not Applicable |
Website Ranks & Scores
Alexa Rank: | Not Applicable |
Domain Authority: | Not Applicable |
Web Server Information
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
H1 Headings: | Not Applicable | H2 Headings: | Not Applicable |
H3 Headings: | 1 | H4 Headings: | Not Applicable |
H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
Total IFRAMEs: | Not Applicable | Total Images: | Not Applicable |
Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Websites Hosted on Same IP (i.e. 54.204.43.126)
Sarepta Therapeutics | Focused on precision genetic medicines to treat
Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in gene therapies for 5 Limb-girdle muscular dystrophy diseases (LGMD), Charcot-Marie-Tooth (CMT), MPS IIIA, Pompe and other CNS-related disorders, totali
The Leader in RNA-based Medicine | Sarepta Therapeutics
We develop RNA-based therapeutics to improve the lives of people affected by serious diseases; this includes eteplirsen for the treatment of DMD.
The Leader in RNA-based Medicine | Sarepta Therapeutics
We develop RNA-based therapeutics to improve the lives of people affected by serious diseases; this includes eteplirsen for the treatment of DMD.
HTTP Header Analysis
Server: nginx
Date: Sat, 31 Aug 2019 20:10:44 GMT
Content-Type: text/html
Content-Length: 970
ETag: "5940b9af-3ca"
Cache-Control: max-age=900, public
Age: 346
Via: varnish
X-Cache: HIT
X-Cache-Hits: 4
Connection: keep-alive
DNS Record Analysis
Host | Type | TTL | Extra |
---|---|---|---|
okta.business | A | 54 |
IP: 54.204.43.126 |
okta.business | NS | 21600 |
Target: ns-cloud-c4.googledomains.com |
okta.business | NS | 21600 |
Target: ns-cloud-c1.googledomains.com |
okta.business | NS | 21600 |
Target: ns-cloud-c2.googledomains.com |
okta.business | NS | 21600 |
Target: ns-cloud-c3.googledomains.com |
okta.business | SOA | 294 |
MNAME: ns-cloud-c1.googledomains.com RNAME: cloud-dns-hostmaster.google.com Serial: 4 Refresh: 21600 Retry: 3600 Expire: 259200 Minimum TTL: 300 |